scholarly article | Q13442814 |
P2093 | author name string | Shuyuan Yeh | |
Chawnshang Chang | |||
Kuo-Pao Lai | |||
Chiung-Kuei Huang | |||
Shinichi Yamashita | |||
P2860 | cites work | The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate | Q24317714 |
P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase | Q24322705 | ||
Inflammation and cancer | Q24649640 | ||
Pten dose dictates cancer progression in the prostate | Q24791909 | ||
PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer | Q27860985 | ||
Immunity, Inflammation, and Cancer | Q27861048 | ||
Increased prostate cell proliferation and loss of cell differentiation in mice lacking prostate epithelial androgen receptor | Q28512229 | ||
Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems | Q28586004 | ||
Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer | Q28590839 | ||
RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement | Q28594711 | ||
Paradoxical roles of the immune system during cancer development | Q29614305 | ||
NF-kappaB: linking inflammation and immunity to cancer development and progression | Q29614597 | ||
Smoldering and polarized inflammation in the initiation and promotion of malignant disease | Q29618034 | ||
TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia | Q29618875 | ||
Early onset of neoplasia in the prostate and skin of mice with tissue-specific deletion of Pten | Q30524175 | ||
Accumulating progenitor cells in the luminal epithelial cell layer are candidate tumor initiating cells in a Pten knockout mouse prostate cancer model | Q33450599 | ||
PTEN, a unique tumor suppressor gene | Q33974014 | ||
Cooperativity of Nkx3.1 and Pten loss of function in a mouse model of prostate carcinogenesis. | Q34014956 | ||
Generation and characterization of androgen receptor knockout (ARKO) mice: an in vivo model for the study of androgen functions in selective tissues | Q34159764 | ||
CCAAT/enhancer-binding protein β and NF-κB mediate high level expression of chemokine genes CCL3 and CCL4 by human chondrocytes in response to IL-1β. | Q34236851 | ||
Pten deletion leads to the expansion of a prostatic stem/progenitor cell subpopulation and tumor initiation | Q34298595 | ||
Androgen receptor promotes hepatitis B virus-induced hepatocarcinogenesis through modulation of hepatitis B virus RNA transcription | Q34546701 | ||
The deficiency of Akt1 is sufficient to suppress tumor development in Pten+/- mice | Q34693888 | ||
Role of stroma in carcinogenesis of the prostate. | Q35030656 | ||
Role of the stromal microenvironment in carcinogenesis of the prostate | Q35202528 | ||
PTEN: tumour suppressor, multifunctional growth regulator and more | Q35203208 | ||
Suppressed prostate epithelial development with impaired branching morphogenesis in mice lacking stromal fibromuscular androgen receptor | Q35640720 | ||
Prostatic intraepithelial neoplasia in genetically engineered mice | Q35747658 | ||
Prostate carcinogenesis and inflammation: emerging insights. | Q35925066 | ||
Identification of a tumour suppressor network opposing nuclear Akt function | Q35991130 | ||
Hormonal, cellular, and molecular regulation of normal and neoplastic prostatic development | Q36017017 | ||
Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression | Q36067596 | ||
Expression of the SM22alpha promoter in transgenic mice provides evidence for distinct transcriptional regulatory programs in vascular and visceral smooth muscle cells | Q36236547 | ||
Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis | Q36384467 | ||
Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer | Q36404654 | ||
Androgen receptor is a tumor suppressor and proliferator in prostate cancer | Q36858442 | ||
Targeting the stromal androgen receptor in primary prostate tumors at earlier stages | Q36858449 | ||
The role of inflammation and infection in the pathogenesis of prostate carcinoma. | Q36896013 | ||
Inflammation, atrophy, and prostate carcinogenesis | Q36934776 | ||
Androgen receptor is a new potential therapeutic target for the treatment of hepatocellular carcinoma. | Q37365527 | ||
Pten in stromal fibroblasts suppresses mammary epithelial tumours | Q37399478 | ||
Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice | Q37452281 | ||
Monocyte/macrophage androgen receptor suppresses cutaneous wound healing in mice by enhancing local TNF-alpha expression | Q37452288 | ||
Differential androgen receptor signals in different cells explain why androgen-deprivation therapy of prostate cancer fails | Q37741773 | ||
Mutation and expression analysis of the putative prostate tumour-suppressor gene PTEN | Q39711051 | ||
Tumor-promoting phenotype of CD90hi prostate cancer-associated fibroblasts | Q39876078 | ||
Sexually transmitted diseases and carcinogenesis | Q40141361 | ||
ASC-J9 ameliorates spinal and bulbar muscular atrophy phenotype via degradation of androgen receptor | Q40164058 | ||
Hic-5/ARA55, a LIM domain-containing nuclear receptor coactivator expressed in prostate stromal cells | Q40253969 | ||
Steroid hormones stimulate human prostate cancer progression and metastasis | Q40343113 | ||
B-cell-derived lymphotoxin promotes castration-resistant prostate cancer | Q40440899 | ||
Malignant transformation in a nontumorigenic human prostatic epithelial cell line. | Q40766949 | ||
A human prostatic stromal myofibroblast cell line WPMY-1: a model for stromal-epithelial interactions in prostatic neoplasia | Q40945599 | ||
Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis | Q41899984 | ||
Nkx3.1; Pten mutant mice develop invasive prostate adenocarcinoma and lymph node metastases | Q44521056 | ||
Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-kappaB-Dependent Manner. | Q46127843 | ||
Allelic loss of chromosome 10q23 is associated with tumor progression in breast carcinomas | Q47814647 | ||
Promotion of bladder cancer development and progression by androgen receptor signals. | Q51758123 | ||
High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice | Q58378937 | ||
Morphologic transitions between proliferative inflammatory atrophy and high-grade prostatic intraepithelial neoplasia | Q73164189 | ||
Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse | Q73435294 | ||
P433 | issue | 8 | |
P921 | main subject | inflammation | Q101991 |
P304 | page(s) | 791-807 | |
P577 | publication date | 2012-06-29 | |
P1433 | published in | EMBO Molecular Medicine | Q15817279 |
P1476 | title | Loss of stromal androgen receptor leads to suppressed prostate tumourigenesis via modulation of pro-inflammatory cytokines/chemokines | |
P478 | volume | 4 |
Q90351679 | A review on the interactions between the tumor microenvironment and androgen receptor signaling in prostate cancer |
Q54976906 | Alcohol-mediated miR-34a modulates hepatocyte growth and apoptosis. |
Q38123063 | Androgen receptor (AR) differential roles in hormone-related tumors including prostate, bladder, kidney, lung, breast and liver |
Q36298863 | Androgen receptor and immune inflammation in benign prostatic hyperplasia and prostate cancer |
Q33977438 | Androgen receptor enhances kidney stone-CaOx crystal formation via modulation of oxalate biosynthesis & oxidative stress |
Q58610787 | Androgen receptor functions as transcriptional repressor of cancer-associated fibroblast activation |
Q46140457 | Androgen receptor in cancer-associated fibroblasts influences stemness in cancer cells. |
Q34194760 | Androgen receptor roles in hepatocellular carcinoma, fatty liver, cirrhosis and hepatitis |
Q38097574 | Androgen receptor roles in the development of benign prostate hyperplasia |
Q36815316 | Animal models of human prostate cancer: the consensus report of the New York meeting of the Mouse Models of Human Cancers Consortium Prostate Pathology Committee |
Q96955153 | Botanical preparation HX109 inhibits macrophage-mediated activation of prostate epithelial cells through the CCL4-STAT3 pathway: implication for the mechanism underlying HX109 suppression of prostate hyperplasia |
Q38205189 | Concise review: androgen receptor differential roles in stem/progenitor cells including prostate, embryonic, stromal, and hematopoietic lineages |
Q36718905 | Development of animal models underlining mechanistic connections between prostate inflammation and cancer |
Q38766770 | Estrogen Receptor Alpha (ERα)-Associated Fibroblasts Promote Cell Growth in Prostate Cancer |
Q52584770 | Genetically Engineered Mouse Models of Prostate Cancer in the Postgenomic Era. |
Q45930927 | High coexpression of CCL2 and CX3CL1 is gender-specifically associated with good prognosis in soft tissue sarcoma patients. |
Q38964798 | Infiltrating T cells promote prostate cancer metastasis via modulation of FGF11→miRNA-541→androgen receptor (AR)→MMP9 signaling |
Q37322631 | Infiltrating macrophages promote prostate tumorigenesis via modulating androgen receptor-mediated CCL4-STAT3 signaling. |
Q37108694 | Loss of androgen receptor promotes adipogenesis but suppresses osteogenesis in bone marrow stromal cells |
Q33940867 | Mouse models of prostate cancer: picking the best model for the question. |
Q36582853 | New therapeutic approach to suppress castration-resistant prostate cancer using ASC-J9 via targeting androgen receptor in selective prostate cells |
Q38342128 | Non-genomic androgen action regulates proliferative/migratory signaling in stromal cells. |
Q49788391 | PTEN Loss Promotes Intratumoral Androgen Synthesis and Tumor Microenvironment Remodeling via Aberrant Activation of RUNX2 in Castration-Resistant Prostate Cancer |
Q34084593 | Personalized medicine for the management of benign prostatic hyperplasia |
Q48255570 | Plumbagin improves the efficacy of androgen deprivation therapy in prostate cancer: A pre-clinical study |
Q38447554 | Prostate stromal cells express the progesterone receptor to control cancer cell mobility |
Q43124532 | Prostate-specific G-protein-coupled receptor collaborates with loss of PTEN to promote prostate cancer progression |
Q34558918 | Reciprocal interaction between carcinoma-associated fibroblasts and squamous carcinoma cells through interleukin-1α induces cancer progression |
Q35762920 | Restoration of Wnt/β-catenin signaling attenuates alcoholic liver disease progression in a rat model |
Q57106160 | Role of Androgen Receptor in Prostate Cancer: A Review |
Q38808593 | Sexual dimorphism in cancer |
Q38743727 | Sorafenib with ASC-J9® synergistically suppresses the HCC progression via altering the pSTAT3-CCL2/Bcl2 signals |
Q37629551 | Stromal Androgen Receptor in Prostate Cancer Development and Progression |
Q36140754 | Stromal androgen receptor regulates the composition of the microenvironment to influence prostate cancer outcome. |
Q38272331 | Stromal androgen receptor roles in the development of normal prostate, benign prostate hyperplasia, and prostate cancer |
Q47163967 | The adaptive immune system promotes initiation of prostate carcinogenesis in a human c-Myc transgenic mouse model. |
Q38741968 | The prognostic value of stromal FK506-binding protein 1 and androgen receptor in prostate cancer outcome. |
Q41963995 | The role of androgen receptor expression in the curative treatment of prostate cancer with radiotherapy: a pilot study |